The stock of Tenax Therapeutics has surged following a corporate update and strong KOL support for TNX-103 in PH-HFpEF. Read the latest analysis on TENX here.
Use of race-based reference equations in pulmonary function testing has led to thresholds for what qualifies as impairment in populations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results